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Abstract
Background: Depression is common in rheumatoid arthritis (RA), however reported prevalence
varies considerably. Two frequently used instruments to identify depression are the Center for
Epidemiological Studies Depression (CES-D) scale, and the Hospital Anxiety and Depression Scale
(HADS). The objectives of this study were to test if the CES-D and HADS-D (a) satisfy current
modern psychometric standards for unidimensional measurement in an early RA sample; (b)
measure the same construct (i.e. depression); and (c) identify similar levels of depression.
Methods: Data from the two scales completed by patients with early RA were fitted to the Rasch
measurement model to show that (a) each scale satisfies the criteria of fit to the model, including
strict unidimensionality; (b) that the scales can be co-calibrated onto a single underlying continuum
of depression and to (c) examine the location of the cut points on the underlying continuum as
indication of the prevalence of depression.
Results: Ninety-two patients with early RA (62% female; mean age = 56.3, SD = 13.7) gave 141
sets of paired CES-D and HAD-D data. Fit of the data from the CES-D was found to be poor, and
the scale had to be reduced to 13 items to satisfy Rasch measurement criteria whereas the HADS-
D met model expectations from the outset. The 20 items combined (CES-D13 and HADS-D)
satisfied Rasch model expectations. The CES-D gave a much higher prevalence of depression than
the HADS-D.
Conclusion: The CES-D in its present form is unsuitable for use in patients with early RA, and
needs to be reduced to a 13-item scale. The HADS-D is valid for early RA and the two scales
measure the same underlying construct but their cut points lead to different estimates of the level
of depression. Revised cut points on the CES-D13 provide comparative prevalence rates.
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Background
Depression is common in rheumatoid arthritis (RA) with
prevalence rates ranging from 13 to 20% [1,2] based on
psychiatric assessment and clinical diagnosis of depres-
sion, and considerably higher when based on self-report
assessment.[3] The co-morbidity of depression in RA
exceeds the rates of depression reported in the general
community (2–4%) and primary care (5–10%).[4]
Depression in RA is closely associated with pain, work dis-
ability, health services utilisation, poor adherence to treat-
ment and suicide.[5]
Regular mood assessment by rheumatology clinical staff
may serve to improve awareness and early identification
of depression,[5] and thus timely identification and treat-
ment of depression in RA is critical to overall clinical man-
agement.[6] While not substituting for a psychiatric
clinical assessment, the use of self-report scales may be a
feasible option in rheumatology settings to identify
patients at risk of depression. Regular screening, and early
intervention or appropriate referral, where necessary,
would provide a psychological 'window of opportunity'
[7] akin to that recommended in relation to clinical treat-
ment of early RA.
While a number of screening instruments for depression
are available, two of the most commonly used scales are
the Hospital Anxiety and Depression Scale (HADS) [8]
and the Center for Epidemiological Studies Depression
(CES-D) scale.[9] The HADS was developed for use in
hospital settings, with items chosen to reduce contamina-
tion with somatic or disease related symptoms. The CES-
D was originally designed for use with the general popu-
lation [9] but has been found to be valid and reliable in
the identification of individuals at high risk of developing
a major depression in clinical populations including
RA.[10] Both scales have been used with RA populations
[1,11-17] and have been subjected to psychometric assess-
ment of their reliability and validity including exploratory
and confirmatory factor analyses.[18,19] In recent years
these traditional psychometric methods have been sup-
plemented by modern psychometric approaches such as
the Rasch measurement model. [20-22] A number of stud-
ies have used Rasch analysis to assess the CES-D, includ-
ing a comparison of stroke versus primary-care
patients;[23] investigation of phone interview versus mail
administration;[24] and the development of a short-form
CES-D.[25] Only one study has tested CES-D in an RA
population [26] and failed to find support for the original
20-item version. A modified 13-item version of the scale
was found to provide a more satisfactory fit to the Rasch
model. Rasch analysis of the HADS has found support for
the psychometric properties of the scale in a musculoskel-
etal sample [27] and a cancer population [28] but has not
been assessed in an RA population.
Given that CES-D and HADS are two of the more com-
monly used depression scales, they serve as a good starting
point to assess whether the case definition of depression
scales is a potential source of the variation in prevalence
of depression reported in the RA literature. This is impor-
tant to establish, as it is not possible to screen all RA
patients with a clinical diagnostic interview, due to cost
and access limitations. A valid self-report scale is therefore
essential if screening for depression is to become routine,
as recommended, [5,29] and be reliably predictive of
depression levels. Rheumatologists should be confident
that the screening instruments available to them identify
the same level of depression or, if not, then there should
be a clear understanding of why this is the case. Therefore,
the aims of this study were to: (a) assess the modern psy-
chometric properties of the CES-D and HADS in a cohort
of early RA patients; (b) to co-calibrate the items from
both scales on to a single metric to determine if they do
measure the same construct, and (c) to compare their
respective cut points for depression to determine if the
variation of reported prevalence may be due to variability
of scale-specific case definition.
Methods
Study Participants
Data from the CES-D and HADS items were obtained
from patients attending the Yorkshire Early Arthritis Reg-
ister clinic in Leeds, UK. The participants met the RA diag-
nosis according to the 1987 American College of
Rheumatology criteria.[30] Ninety-two early-RA partici-
pants (62% female; mean age = 56.3, SD = 13.7) were
assessed twice within a six month period. The majority of
patients (66%) had RA duration of less than two years, the
remaining around three years. Patients received standard
disease modifying anti-rheumatic drugs (DMARD) ther-
apy according to a predetermined local protocol. Ethical
approval was granted by the relevant Research Ethics
Committee, under a programme of work for the analysis
of common musculoskeletal outcome measures.
Measures
CES-D is a 20-item scale designed to measure depressive
symptoms experienced in the past week.[9] Responses
range from 0 to 3 where 0 = Rarely or none of the time (less
than 1 day); 1 = Some or a little of the time (1–2 days); 2 =
Occasionally or a moderate amount of the time (3–4 days);
and 3 = Most or all of the time (5–7 days). Four of the items
are positively worded and are reverse-scored before add-
ing all items to give a total CES-D score. Scores range from
0 to 60, with a cut-off of 16 indicative of probable clinical
depression.[9] A higher cut-off of 19 has been suggested
in the RA population and other primary care clinical pop-
ulations as a more optimal scale sensitivity point that
avoids 'false-positive' identification of depression cases.
[31]BMC Musculoskeletal Disorders 2009, 10:18 http://www.biomedcentral.com/1471-2474/10/18
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HADS is a 14-item scale consisting of two 7-item subscales
measuring depression and anxiety on a 4-point response
scale ('0' indicating absence of symptoms, to '3' indicating
maximum symptoms). [8] Subscale scores range from 0 to
21, with higher scores indicating higher levels of depres-
sion and/or anxiety. Scores between 0 and 7 represent no
case; 8 to 10 indicates possible case and 11 to 21 suggest a
probable case of depression/anxiety.[8] In this study only
the HADS-Depression subscale (HADS-D) was used.
Rasch Analysis
Rasch analysis takes its name from the Danish mathema-
tician Georg Rasch.[20]. He introduced a model which
specifies what is needed to construct interval level meas-
urement from ordinal scales (e.g. those typically derived
from questionnaires), and consequently it acts as a tem-
plate against which the data can be evaluated. There are
versions of the model for scales which have dichotomous
items, and polytomous items. [20,21,32] The process of
Rasch analysis is an iterative procedure which assesses fit
of data to the model, a number of measurement
attributes, as well as the assumptions which underpin the
model. [27,33] In RUMM2020,[34] the Rasch analysis
package used in this study, three overall fit statistics to
assess fit of data to the model are considered; two of
which are item-person interaction statistics transformed
to approximate a z-score, representing a standardized nor-
mal distribution. Therefore when the items and persons
fit the model the mean is approximately zero with a stand-
ard deviation of 1. A third summary fit statistic is an item-
trait interaction statistic reported as a Chi-Square. A signif-
icant Chi-Square indicates that there is deviation from
model expectations and is indicative of poor fit. In addi-
tion to these overall summary fit statistics, individual per-
son and item fit statistics are presented, both as residuals
and as a chi square statistic. In the former case, residuals
between ± 2.5 are deemed to indicate adequate fit to the
model. A chi-square test is also available for each item and
again good fit to model expectations would be indicated
by a non-significant value. To take account of multiple
testing, Bonferroni corrections are applied to adjust the
Chi-Square p value.[35]
Other aspects of Rasch analysis are concerned with testing
model assumptions, such as local dependency and unidi-
mensionality, and with the investigation of other
attributes such as appropriate category response structure
(for polytomous items) and for item bias, or Differential
Item Functioning (DIF).[36] Local dependency is identi-
fied through correlations in the residuals, typically above
0.3. Unidimensionality is an assumption of the Rasch
model and within RUMM2020 this is tested by a compar-
ison of two independent estimates for the same person,
based upon different sets of items identified by the princi-
pal component analysis of the residuals [37]. Less than
5% of the tests should be significantly different (or the
lower bound of the binomial confidence interval should
overlap 5%) for the scale to be considered unidimen-
sional
For polytomous items, the assumption of the rating scale
version of the model is that the distances between thresh-
olds (the transition point between response categories)
must be equal across all items [21] otherwise an unre-
stricted, or partial credit version of the model is used.[32]
Thresholds must also show an increase consistent with the
underlying trait (that is, an increase in the response
option is associated with an increase in the underlying
trait), else they are considered 'disordered' which can
affect fit statistics. In these circumstances categories are
often collapsed to improve fit.
Finally a measure of reliability is provided in the form of
a Person Separation Index, which can be interpreted as a
Cronbach's alpha. Although the number of items in the
scale need to be taken into account, typically values of 0.7
and above are considered suitable for group use, and 0.85
and above for individual use.[38] This is closely linked to
the targeting of the scale as it differentiates the number of
statistically distinct groups of respondents that can be
identified on the trait.[39] Given these procedures, ade-
quate fit to the Rasch model, confirmation of unidimen-
sionality and freedom from item bias (DIF) support the
internal construct validity of the scale. [40,41]
Results
From the 92 participants at time 1 and 2, 141 sets of
paired CES-D and HAD-D data were usable for Rasch
analyses. In both cases, the unrestricted or partial credit
version of the model was found to be most appropriate.
Rasch Analysis of CES-D
CES-D scores ranged from 0 to 55 with a mean of 16.7 (SD
= 11.3). Initial inspection of the scale showed poor overall
fit to the Rasch model as indicated by a significant item
trait interaction (χ2 = 314.148, df = 40, p < 0.001) and
item fit residual values outside the acceptable range
(mean = -0.139, SD = 2.588).
Ten of the items were found to have disordered thresh-
olds, suggesting problems with the 4-point response for-
mat used for the scale. It was therefore decided to rescore
all items by merging the two middle categories ('some or a
little of the time' and 'occasionally or a moderate amount of the
time') thus reducing the scoring to a 3-point format from
0123 to 0112, and making the overall score range 0 to 40.
Following this, seven misfitting items were identified with
significant chi-square probability values or high positive
or high negative residual values (± 2.5). Items wereBMC Musculoskeletal Disorders 2009, 10:18 http://www.biomedcentral.com/1471-2474/10/18
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removed one at the time, based on the magnitude of the
significant chi-square probability value and positive or
negative residual values, with the overall model fit and
individual item statistics checked after each step, until all
remaining items were shown to fit model expectations
(Table 1). The seven removed items were items: 2, 4, 8, 11,
12, 16 & 18.
The final solution, retaining 13 items, showed overall fit
to the model (Table 2). The person separation reliability,
which is equivalent to Cronbach's alpha was found to be
high (PSI = 0.916), making it suitable for individual use.
The items of the CES-D13 scale were assessed for differen-
tial item functioning (DIF) across time (1 and 2), gender
(male/female), and age (3 groups: ≤ 53 yrs; 54–65 yrs; 66+
yrs) using a Bonferroni-adjusted alpha value. The only sig-
nificant DIF was found on Item 3 ('I felt that I could not
shake off the blues even with help from my family or friends')
for gender, with females more likely to endorse it than
males (p = 0.0005). As overall fit to the model was
achieved it was decided not to remove this item and to
retain it for further investigation.
To test the unidimensionality of the CES-D13 scale, a
Principal Components Analysis of the residuals was con-
ducted to identify the two most divergent subsets of items
as indicated by positive and negative loading items on the
first component extracted. Comparison of the person esti-
mates generated from these two subsets indicated that
eight (7.41%) of the 108 t-tests showed significant differ-
ences in the estimates generated, which was non-signifi-
cant when a 95% confidence interval from a Binomial
distribution was applied. This supports the unidimen-
sionality of the CES-D13 scale.
Rasch Analysis of HADS – Depression (HADS-D)
HADS-Depression scores ranged from 0 to 20 with a mean
of 7.4 (SD = 4.2). The seven items of the HADS-D scale
showed satisfactory fit to the Rasch (Table 2). All items
showed ordered thresholds, indicating appropriate use of
the response format. There was no evidence of item or per-
son misfit. No differential item functioning was found for
time, gender or age. Principal component analysis of the
residuals identified two sets of contrasting items from
which individual person estimates were obtained. Only
six (5.13%) of the t-tests showed significant differences in
the estimates generated from each subset of items, which
was non-significant when a 95% confidence interval from
a Binomial distribution was applied. This supports the
unidimensionality of the 7-item HADS-D scale.
Rasch Analysis of the combined items from the CES-D13 
and HADS-D
Data from the CES-D13 and HADS-D were combined and
showed satisfactory fit to the Rasch model (Table 2).
Although some marginal threshold disturbance was evi-
dent in one CES-D13 and three HADS-D items, these were
left unaltered as the overall fit of the model was satisfac-
tory. One CES-D13 item (item 3) showed significant uni-
form DIF, with higher endorsement by females than
males (p = 0.0006). Given overall fit to the model, the
item was retained. Principal component analysis of the
residuals revealed a set of positive and negative loading
items, a mixture from both scales. Comparing estimates
based upon these subsets, 11 (7.86%) of the 140 t-tests
showed significant differences in the estimates generated,
which was non-significant when a 95% confidence inter-
val from a Binomial distribution was applied. This sup-
ports the unidimensionality of the combined CES-D13
and HADS-D items demonstrating that both scales meas-
ure the same underlying construct.
Figure 1 shows the person item distribution of the 20 co-
calibrated items, suggesting that the HADS-D has a better
distribution of items across the range of depression than
does the CES-D13. With the exception of item 19, the
Table 1: Final fit of the CES-D items to the Rasch model
CESD
Item
CESD Item Name Location SE Fit Res DF ChiSq. DF Prob.
1 Bothered -0.617 0.197 0.175 97.57 1.468 2 0.479
3 Blues 0.100 0.211 -2.028 96.67 7.553 2 0.023
5 Concentrate -0.909 0.192 0.380 96.67 0.802 2 0.669
6 Depressed -0.486 0.210 -1.973 95.76 6.573 2 0.037
7 Effort -1.920 0.183 1.025 94.86 6.853 2 0.032
9 Failure 0.143 0.208 -0.279 96.67 0.196 2 0.907
10 Tearful -0.394 0.205 -1.853 94.86 2.659 2 0.264
13 Talked less 0.065 0.212 0.969 94.86 0.192 2 0.908
14 Lonely -0.071 0.209 -1.127 93.95 2.031 2 0.362
15 Others unfriendly 0.899 0.267 0.714 94.86 6.561 2 0.037
17 Crying spells 0.211 0.216 -0.434 95.76 1.261 2 0.532
19 Others dislike 4.539 0.321 -0.747 95.76 0.659 2 0.719
20 Not get going -1.560 0.198 -0.061 95.76 0.290 2 0.865BMC Musculoskeletal Disorders 2009, 10:18 http://www.biomedcentral.com/1471-2474/10/18
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majority of CES-D13 items are clustered within the centre
of the scale. The two scales taken together appear to offer
a wider measurement of depression than each scale on
their own.
Comparison of CES-D and HADS-D Case Ascertainment
The difference in levels of depression expressed by items
in the CES-D in its various forms and the HADS-D are
shown in Table 3. The cut points for the HADS give a prev-
alence of possible and probable depression as 22.6% and
9.7% respectively. In contrast the cut-off value (16) to
identify depression for the 20-item CES-D scale [9] gives a
prevalence of 45.3%, while the RA-specific cut value of 19
[31] gives a prevalence of 35.9%. As such the depression
prevalence is much higher for the CES-D than the HADS-
D. The equivalent cut points for possible  and  probable
depression in early RA on the revised CES-D13 would be
9 (possible case – that is the equivalent of an 8 on the
HADS-D) and 13 (probable case) respectively, derived
from the 13-item scale scored 0112 (i.e. a total score range
on 0–26). Based on those cut points, 26.6% of the partic-
ipants had possible depression and 8.1% probable cases
of depression, closely aligned to the rates identified by the
HADS-D. Given the prevalence from the HADS-D corre-
sponds most closely with the reported prevalence based
on psychiatric interview, this scale would seem most suit-
able to offer as an 'interim' gold standard for comparing
other scales, in the absence of further clinical interviews.
Discussion
The aim of this study was to test a number of issues asso-
ciated with using self-report scales to screen for depressive
symptoms in an early RA population. Using a modern
psychometric approach, namely Rasch analysis, data from
two widely used scales for depression were collected con-
currently and initially tested against Rasch model require-
ments, including unidimensionality. Once these
conditions were satisfied, items from the two scales were
co-calibrated onto a single measure of depression to dem-
onstrate that they target the same construct, which
allowed for comparison of their cut points.
Several significant findings emerged. The 20-item version
of the CES-D was found to lack adequate fit to Rasch
model expectations, and needed revising to a 13-item
scale. Problems with the 20-item version of the CES-D
have been identified previously, for example, in a longitu-
dinal RA study.[26] Four (items 4, 8, 12 & 16) of the seven
items removed were positively worded and it has been
suggested in other studies [25,42] that such items may not
measure the same construct as the negatively worded
items. The remaining three (2, 11 & 18) removed items
relate to somatic features (appetite and sleep) and
depressed affect (sadness). Problems with somatic items
in CES-D have also been noted in previous studies with
RA population. [10,14,43,44] In addition, the response
format also needed modification to more accurately
reflects participants' responses. Our findings correspond
to those reported in relation to the use of CES-D with a
more established RA population [26] and suggest that this
modified version, CES-D13 may be more clinically useful
than the original 20-item CES-D.
Individually, the revised CES-D13 scale and the HADS-D
were found to meet Rasch model expectations, and to sat-
isfy strict tests of unidimensionality. It is important to
note that unidimensionality is a requirement for summat-
ing any set of items [45], even where the scale may consist
of related factors such as negative affect and somatic fea-
tures, as in the case of depression. It is also important to
note that unidimensionality is a necessary, but not suffi-
cient, condition for satisfying Rasch model expectations,
as the model imposes extra constraints on the data to sat-
isfy the rules for constructing interval scale data [46]. Con-
sequently whether or not measurement of a single
construct such as depression can be achieved is an empir-
ical question. Given the pooled item set (CES-D13 +
HADS-D) also satisfied Rasch model expectations and
unidimensionality tests, this confirms that the two scales
do indeed measure the same underlying unidimensional
construct.
The variation in reported prevalence of the two scales may
be partly explained by the somatic and positive items in
the CES-D as well as CES-D being only an indication of
depression rather than diagnosis of clinical depression.
Furthermore, the lack of unidimensionality in the original
CES-D suggests that the 20-item scale measures two differ-
ent, if related, constructs which may inflate the score and
therefore, indication of depression. Both the 20-item scale
Table 2: Overall Rasch model fit statistics
Scale χ2 p Item
Fit Residual mean (SD)
Person
Fit Residual mean (SD)
20-item CES-D 314.15 0.00 -0.14 (2.59) -0.10 (1.03)
13-item CES-D 37.10 0.07 -0.40 (1.08) -0.36 (1.11)
7-item HADS-D 16.78 0.27 -0.23 (0.61) -0.29 (0.77)
CES-D13+HADS-D 58.37 0.03 -0.14 (0.85) -0.27 (1.16)BMC Musculoskeletal Disorders 2009, 10:18 http://www.biomedcentral.com/1471-2474/10/18
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Item map showing location values for the combined items of the CES-D13 and HADS-D Figure 1
Item map showing location values for the combined items of the CES-D13 and HADS-D. The item map shows the 
relative positioning of the items in terms of their difficulty. CES-D item 19 is the most difficult item to endorse and therefore 
indicative of the severe end of the levels of depression, whereas HADS-D item 8 is the least difficult item to endorse and 
therefore indicative of the lowest of depression levels.
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and the 13-item version of the CES-D displayed at least
one item with DIF, and there are issues about the poten-
tial bias which may be introduced under such circum-
stances. Although uniform DIF may be adjusted within
the framework of the Rasch measurement model [47], this
is not something that can be addressed easily within a rou-
tine use of this scale in a clinical setting.
In contrast, the convergence of the HAD-D cut points with
the range reported for psychiatric interview would appear
to make this scale a useful indicator of a clinical depres-
sion and as such a baseline comparator for other scales, as
illustrated with the CES-D13 in this study. Indeed, in the
absence of clinical diagnostic interviews, the HADS-D can
be used as an interim 'gold standard'. Since the modified
version of the CES-D contains a reduced response format,
further investigation is necessary to confirm its appropri-
ateness, to test-retest the modified scale, and ascertain the
positive predictive value of the CES-D (and indeed the
HADS-D as well), to determine the scale's utility within a
routine clinical setting. Furthermore, given the variability
of case ascertainment across the two scales in the current
study, further research would appear necessary with other
commonly used depression scales (e.g. Beck's Depression
Inventory[48]) to see if they too measure the same con-
struct, and to ascertain their comparative cut points.
There are a number of limitations to this study. The sam-
ple size is small and is at the viable lower limit for Rasch
analysis. This would give a degree of precision of person
and item estimate to within just under one logit, which
may affect the estimate of sensitivity and specificity. The
study population is patients with early RA, and while the
findings are consistent to those reported in another cohort
of patients with RA [26] further replication is necessary. In
the current study no clinical assessment of depression was
conducted to provide formal evaluation of cut point sen-
sitivity and specificity of the combined scale, although the
prevalence using the HADS-D and the revised CES-D13 is
consistent with reported rates for depression in RA using
clinical interviews.
The results of this study have a number of implications for
research and practice. The current study suggests that var-
iation in prevalence of depression may be a function of
the scale used, and many existing scales may give rise to
high numbers of false positives in an early RA sample.
Where scales are used to identify depression and referral
for treatment, the HADS-D appears to provide estimates
consistent with clinical diagnostic interviews and thus
rheumatologists and others can have some confidence in
case ascertainment using this scale. If the CES-D is rou-
tinely collected, then the revised 13-item version and
modified cut points would provide similar caseness,
although further work needs to be done to confirm the
internal construct validity of this modified version, as well
as criterion validity to confirm sensitivity, specificity and
the positive predictive power of the test using these cut
points.
Eventually other depression scales, in addition to CES-D
and HADS-D, which are shown to measure the same con-
struct can be all calibrated onto a single metric 'item bank'
[49] which will pave the way for the development of a
computer adaptive testing approach [50] to provide a sim-
ple screening tool suitable for use within a rheumatology
clinic to allow early identification of depression in RA.
In addition, comparison of scales, such as conducted in
this study, provides insight into the variability of the levels
of depression detected across studies. It also contributes
towards a better understanding of the impact of depres-
sion upon, for example, quality of life, when adjusted for
the variability of case identification across different
screening instruments. In the meantime, the HADS-D can
offer the rheumatologist reliable and valid comparative
screening for depression in early rheumatoid arthritis. The
CESD-13 requires further work concerning reliability and
validity of its response structures, but the cut points given
above will allow for comparison of existing data sets
where the two scales have been used. Clinicians can have
confidence that those patients identified as probable cases
by the cut points given on either scale will, in existing data
sets, be indicative of a possibly clinical depression suffi-
cient for referral and further assessment. For prospective
studies, the HADS-D provides the better option of the two
scales reviewed.
Conclusion
The HADS-D met Rasch model expectations and appears
to be a useful self-report scale for screening for depression
in early RA, as it identifies levels of depression consistent
with those reported in other studies using clinical diag-
nostic interviews. In contrast, the CES-D required modifi-
cation for use in early RA, and its response structure also
necessitated collapsing from a four to a three-category
structure. The cut points on the both original CES-D and
modified CES-D13 gave much higher levels of possible
depression compared to the HADS-D, and may require
Table 3: Depression cut-off scores and case percentages
Scale Cut-off Score %
HADS-D 11 (probable case) 9.7
HADS-D 8 (possible case) 22.6
20-ITEM CES-D 19 (RA cut-off) 35.9
20-ITEM CES-D 16 (standard cut-off) 45.3
CES-D13 9 (probable case) 8.1
CES-D13 13 (possible case) 26.6BMC Musculoskeletal Disorders 2009, 10:18 http://www.biomedcentral.com/1471-2474/10/18
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adjusting, if, for the present time, the HADS-D is consid-
ered to be an interim gold-standard. However, the HADS-
D and the CES-D13 did successfully co-calibrate on to the
same metric, suggesting that they do indeed measure the
same construct. Taken together the two scales appear to
offer a more comprehensive measure of depression in that
their combined width of the depression construct is wider
than either scale on their own.
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